Squamous Non-Small Cell Lung Cancer Therapeutics Market Report

China Squamous Non-Small Cell Lung Cancer Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 02, 2023
  • PAGES：135
  • REPORT CODE：GMM1771867
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Squamous Non-Small Cell Lung Cancer Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Five Prime Therapeutics, Inc

    • Oncogenex Pharmaceuticals, Inc

    • PsiOxus Therapeutics Limited

    • Bayer AG

    • F Hoffmann-La Roche Ltd

    • BIND Therapeutics, Inc

    • Eli Lilly and Company

    • Incyte Corporation

    • AVEO Pharmaceuticals, Inc

    • AstraZeneca Plc

    • Ascenta Therapeutics, Inc

    • Bristol-Myers Squibb Company

    • Johnson & Johnson

    • Novartis AG

    By Type:

    • Ipilimumab

    • Buparlisib Hydrochloride

    • Others

    • BMS-906024

    • FP-1039

    • JNJ-42756493

    • Lenvatinib

    By Application:

    • Clinic

    • Hospital

    • Research Center

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Overview 2018-2029

    • 1.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Industry Development Overview

    • 1.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Industry Development History

    • 1.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of Ipilimumab (2018-2029)

      • 1.4.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of Buparlisib Hydrochloride (2018-2029)

      • 1.4.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of BMS-906024 (2018-2029)

      • 1.4.5 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of FP-1039 (2018-2029)

      • 1.4.6 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of JNJ-42756493 (2018-2029)

      • 1.4.7 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of Lenvatinib (2018-2029)

    • 1.5 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)

    • 1.6 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis by Region

      • 1.6.1 North China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Squamous Non-Small Cell Lung Cancer Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Squamous Non-Small Cell Lung Cancer Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Squamous Non-Small Cell Lung Cancer Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Squamous Non-Small Cell Lung Cancer Therapeutics Industry Development

    Chapter 3 Squamous Non-Small Cell Lung Cancer TherapeuticsIndustry Chain Analysis

    • 3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Chain

    • 3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Squamous Non-Small Cell Lung Cancer Therapeutics Market

    • 3.3 Squamous Non-Small Cell Lung Cancer Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Squamous Non-Small Cell Lung Cancer Therapeutics Market

    Chapter 4 China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 4.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of Ipilimumab

      • 4.5.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of Buparlisib Hydrochloride

      • 4.5.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of Others

      • 4.5.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of BMS-906024

      • 4.5.5 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of FP-1039

      • 4.5.6 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of JNJ-42756493

      • 4.5.7 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of Lenvatinib

    Chapter 5 China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Clinic

      • 5.5.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Hospital

      • 5.5.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Research Center

    Chapter 6 China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Region

    • 6.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 7.1 North China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 7.2 North China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    Chapter 8 Central China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 8.1 Central China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 8.2 Central China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    Chapter 9 South China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 9.1 South China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 9.2 South China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    Chapter 10 East China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 10.1 East China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 10.2 East China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    Chapter 11 Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 11.1 Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 11.2 Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    Chapter 12 Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 12.1 Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 12.2 Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    Chapter 13 Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 13.1 Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 13.2 Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Five Prime Therapeutics, Inc

        • 14.1.1 Five Prime Therapeutics, Inc Company Profile

        • 14.1.2 Five Prime Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Oncogenex Pharmaceuticals, Inc

        • 14.2.1 Oncogenex Pharmaceuticals, Inc Company Profile

        • 14.2.2 Oncogenex Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 PsiOxus Therapeutics Limited

        • 14.3.1 PsiOxus Therapeutics Limited Company Profile

        • 14.3.2 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bayer AG

        • 14.4.1 Bayer AG Company Profile

        • 14.4.2 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 F Hoffmann-La Roche Ltd

        • 14.5.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.5.2 F Hoffmann-La Roche Ltd Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 BIND Therapeutics, Inc

        • 14.6.1 BIND Therapeutics, Inc Company Profile

        • 14.6.2 BIND Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Eli Lilly and Company

        • 14.7.1 Eli Lilly and Company Company Profile

        • 14.7.2 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Incyte Corporation

        • 14.8.1 Incyte Corporation Company Profile

        • 14.8.2 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 AVEO Pharmaceuticals, Inc

        • 14.9.1 AVEO Pharmaceuticals, Inc Company Profile

        • 14.9.2 AVEO Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 AstraZeneca Plc

        • 14.10.1 AstraZeneca Plc Company Profile

        • 14.10.2 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Ascenta Therapeutics, Inc

        • 14.11.1 Ascenta Therapeutics, Inc Company Profile

        • 14.11.2 Ascenta Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Bristol-Myers Squibb Company

        • 14.12.1 Bristol-Myers Squibb Company Company Profile

        • 14.12.2 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Johnson & Johnson

        • 14.13.1 Johnson & Johnson Company Profile

        • 14.13.2 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Novartis AG

        • 14.14.1 Novartis AG Company Profile

        • 14.14.2 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Research Conclusions

    • 15.2 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Industry Market Size (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of Ipilimumab (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of Buparlisib Hydrochloride (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of BMS-906024 (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of FP-1039 (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of JNJ-42756493 (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume, Production Value and Growth Rate of Lenvatinib (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)

    • Figure North China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Squamous Non-Small Cell Lung Cancer Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type in 2018

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type in 2023

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of Ipilimumab (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of Buparlisib Hydrochloride (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of BMS-906024 (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of FP-1039 (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of JNJ-42756493 (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume and Growth Rate of Lenvatinib (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application in 2018

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application in 2023

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Research Center (2018-2023)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume by Region (2018-2023)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Production Value by Region (2018-2023)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Value Share by Region (2018-2023)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume by Region (2018-2023)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value by Region (2018-2023)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table North China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table South China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table East China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Five Prime Therapeutics, Inc Company Profile

    • Table Five Prime Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Oncogenex Pharmaceuticals, Inc Company Profile

    • Table Oncogenex Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table PsiOxus Therapeutics Limited Company Profile

    • Table PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table BIND Therapeutics, Inc Company Profile

    • Table BIND Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Incyte Corporation Company Profile

    • Table Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AVEO Pharmaceuticals, Inc Company Profile

    • Table AVEO Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Plc Company Profile

    • Table AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Ascenta Therapeutics, Inc Company Profile

    • Table Ascenta Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US